Latest RMTI reports update at 2024-03-21: 20232022
Rockwell Medical logo
Rockwell Medical RMTI
$ 1.65 3.12%

Rockwell Medical Financial Ratios 2011-2024 | RMTI

Annual Financial Ratios Rockwell Medical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.2 -1.1 -1.2 -2.8 -4.9 -4.8 -11.0 -14.2 -21.6 -20.9 -7.1 -2.4 -8.7

P/S

0.4 0.3 0.6 1.4 2.7 2.4 5.0 5.3 5.6 8.2 6.6 2.6 3.8

EPS

-0.4 -1.3 -3.8 -0.4 -0.6 -0.6 -0.5 -0.4 -0.3 -0.5 -1.5 -2.6 -1.2

EV (Enterprise Value)

57.3 M 42.9 M 71.2 M 81.1 M 179 M 156 M 303 M 295 M 306 M 410 M 369 M 153 M 194 M

EBITDA per Share

-0.22 -1.13 -3.48 -0.419 -0.516 -0.582 -0.5 -0.383 -0.287 -0.4 -1.4 -2.61 -1.16

EV/EBITDA

-13.7 -1.3 -4.9 -4.2 -10.9 -13.6 -19.6 -23.0 -7.7 -2.4 -8.8

PEG

-0.04 -0.01 -0.01 -0.12 -0.59 0.24 0.36 0.41 -0.49 -0.32 -0.16 0.02 0.01

P/B

1.7 1.5 15.2 2.5 8.2 5.6 8.7 5.3 5.0 6.5 578.9 -13.1 10.2

P/CF

-3.8 -1.2 -1.1 - -5.8 -7.2 -12.5 -22.0 -18.3 125.0 -6.7 -4.2 -16.4

ROE %

-39.64 -132.42 -1288.92 -90.40 -167.96 -117.78 -78.76 -37.39 -23.14 -31.04 -8191.46 542.28 -117.54

ROA %

-16.18 -40.05 -67.27 -39.73 -77.01 -61.12 -44.10 -23.81 -16.42 -21.76 -134.16 -317.31 -67.14

ROCE %

-31.33 -118.96 -1196.69 -47.56 -106.74 -79.81 -52.23 -27.68 -18.94 -19.91 -254.20 544.70 -118.84

Current Ratio

1.7 1.4 1.1 5.4 3.0 3.5 5.3 7.7 10.5 9.7 1.8 0.5 1.9

DSO

37.5 30.5 29.7 24.5 25.0 42.3 40.5 43.8 33.3 30.1 31.9 32.5 31.5

DIO

28.5 26.3 22.7 24.0 22.8 22.7 52.0 95.2 61.9 31.3 22.4 22.4 21.1

DPO

20.9 20.7 22.4 25.5 18.8 25.2 28.8 46.0 31.4 42.3 69.3 125.5 45.2

Operating Cycle

65.9 56.8 52.4 48.5 47.8 65.0 92.5 139.0 95.2 61.5 54.3 54.9 52.6

Cash Conversion Cycle

45.0 36.1 30.0 23.0 28.9 39.8 63.7 93.1 63.8 19.1 -15.1 -70.6 7.4

All numbers in USD currency

Quarterly Financial Ratios Rockwell Medical

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.07 -0.18 -0.1 - -0.23 -0.43 -0.84 - -0.89 -0.99 -0.91 - -0.1 -0.1 -0.12 - -120 -0.18 -0.15 - -0.1 -0.24 -0.13 -0.18 -0.1 -0.14 -0.09 -0.1 -0.09 -0.11 -0.1 -0.12 -0.05 -0.05 -0.07 -0.14 -0.1 -0.08 -0.2 -0.21 -0.34 -0.38 -0.72 -0.66 -0.86 -0.58 -0.54 -0.49 -0.28 -0.26 -0.17

EBITDA per Share

-0.05 -0.15 -0.07 - -0.2 -0.38 -0.76 - -0.75 -0.87 -0.82 - -0.08 -0.07 -0.12 - - -0.17 -0.15 - -0.09 -0.23 -0.11 -0.18 -0.09 -0.13 -0.1 -0.1 -0.08 -0.1 -0.09 -0.12 -0.04 -0.04 -0.07 -0.1 -0.06 -0.05 -0.17 -0.19 -0.3 -0.36 -0.71 -0.64 -0.82 -0.56 -0.53 -0.48 -0.23 -0.23 -0.14

ROE %

-83.31 -100.57 -90.54 98.37 30.03 -12.33 -33.82 -144.09 -165.60 -118.78 -92.81 -65.05 -103.70 -120.85 -151.33 -132.02 -150.24 -129.80 -123.99 -83.40 -110.87 -108.01 -84.69 -78.76 -60.84 -54.09 -42.69 -37.39 -37.11 -32.37 -26.31 -23.14 -23.17 -25.07 -25.62 -31.04 -1420.84 -3632.93 -5620.33 -8191.46 -6655.11 -4257.80 -2146.28 542.28 355.96 148.88 4.50 -117.54 -27.63 -24.87 -15.96

ROA %

-24.30 -28.48 -28.19 -35.27 -48.18 -53.36 -58.15 -37.27 -46.72 -43.26 -38.94 -28.59 -46.31 -54.58 -68.94 -60.53 -69.99 -61.72 -61.77 -43.29 -58.66 -57.81 -46.59 -44.10 -34.80 -31.68 -26.08 -23.81 -24.31 -21.57 -18.01 -16.42 -16.36 -17.66 -18.01 -21.76 -38.16 -70.44 -99.83 -134.16 -191.56 -260.23 -297.53 -317.31 -265.02 -175.81 -120.09 -67.14 -15.78 -14.21 -9.12

ROCE %

-73.49 -88.39 -79.59 92.61 29.77 -10.10 -30.83 -133.26 -152.84 -109.57 -82.99 -59.55 -98.63 -118.14 -152.78 -133.48 -151.80 -131.05 -125.09 -84.37 -112.39 -109.33 -84.66 -78.76 -60.68 -54.39 -44.53 -38.16 -37.95 -33.11 -26.81 -24.23 -21.81 -22.24 -21.45 -25.56 -1282.48 -3354.08 -5327.92 -7901.96 -6500.36 -4244.34 -2146.76 544.70 358.24 150.34 4.76 -118.85 -28.04 -25.30 -16.43

Current Ratio

1.7 1.3 1.4 1.4 1.4 1.5 0.9 1.1 1.2 1.4 1.6 1.8 1.8 1.8 1.8 1.9 1.9 1.9 1.9 2.1 2.1 2.1 2.1 2.3 2.3 2.3 2.3 - - - - - - - - - - - - - - - - - - - - - - - -

DSO

28.4 28.9 28.5 - 37.7 37.1 36.9 - 32.5 36.0 31.8 - 6.3 6.3 6.4 - 24.9 25.8 32.8 - 38.2 42.7 40.7 - 39.6 43.8 39.9 - - - - - - - - - - - - - - - - - - - - - - - -

DIO

23.9 30.5 30.5 - 26.0 28.8 25.9 - 24.3 26.1 24.3 - 23.9 23.8 23.4 - 21.6 23.6 24.1 - 25.1 19.5 34.0 - 51.4 59.3 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

20.9 29.8 24.7 - 15.3 19.3 21.5 - 27.3 24.4 22.6 - 25.4 25.2 22.2 - 17.9 19.5 23.6 - 27.9 21.6 25.4 - 28.4 32.8 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

52.2 59.4 59.0 - 63.7 66.0 62.8 - 56.9 62.1 56.1 - 30.2 30.1 29.8 - 46.5 49.4 56.9 - 63.3 62.2 74.7 - 91.1 103.1 39.9 - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

31.4 29.6 34.2 - 48.4 46.7 41.3 - 29.5 37.7 33.5 - 4.9 4.9 7.6 - 28.6 29.9 33.3 - 35.4 40.5 49.3 - 62.6 70.3 39.9 - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency